financetom
Business
financetom
/
Business
/
US Steel Stock Is Falling Thursday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Steel Stock Is Falling Thursday: What's Going On?
Apr 10, 2025 6:41 AM

United States Steel Corp ( X ) shares are facing selling pressure on Thursday after President Donald Trump suggested he doesn't want to see the company get acquired by Nippon Steel.

What To Know: In a press conference from the Oval Office after the market close on Wednesday, Trump told reporters he wants U.S. Steel to remain a U.S. company. 

"We don't want to see it go to Japan. You know, we love Japan, but U.S. Steel is a very special company," Trump said.

U.S. Steel and Nippon Steel filed lawsuits in January after the Biden administration blocked Nippon’s proposed $14.9-billion acquisition of U.S. Steel, originally announced at the end of 2023. The companies claimed “wrongful interference” with the planned takeover deal.

The Biden administration said last year that it was "vital" that U.S. Steel remained a domestically operated American steel company. The proposed acquisition had become a major topic of discussion leading up to the presidential election in November.

U.S. Steel shares surged earlier this week after Trump ordered a national security review of the company's blocked deal with Nippon Steel. The stock reversed course following Trump’s comments late Wednesday.

"If you go back to U.S. Steel from 90 years ago, it’s incredible. It was the number one company in the world for a long time. That's why we don't want to see it go to Japan,” Trump said.

X Price Action: U.S. Steel shares were down 11.6% at $39.91 at the time of publication Thursday morning, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved